{"version": "https://jsonfeed.org/version/1.1", "title": "Sharemaestro Newsreel: France Healthcare news", "home_page_url": "https://sharemaestro.com/newsreel/fr/healthcare/", "feed_url": "https://sharemaestro.com/newsreel/fr/healthcare/feed.json", "description": "Latest Healthcare company headlines from France, newest first, with industry sections, source links and company research.", "language": "en", "items": [{"id": "source:bb643f1225912a251281d0e87f94542ea3b32a3d4977d536396cbe0b42f96c8c", "url": "https://finance.yahoo.com/markets/world-indices/articles/european-equities-traded-us-american-150802661.html", "external_url": "https://finance.yahoo.com/markets/world-indices/articles/european-equities-traded-us-american-150802661.html", "title": "European Equities Traded in the US as American Depositary Receipts Track Lower in Friday Trading", "content_text": "European equities traded in the US as American depositary receipts were tracking lower late Friday morning, declining 0.35% to 1,962.14 on the S&P Europe Select ADR Index, which is up 0.17% for the week so far.From continental Europe, the gainers were led by semiconductor company Silver Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium news articles. Upgrade now", "date_published": "2026-08-14T15:08:02+00:00", "authors": [{"name": "finance.yahoo.com"}], "tags": ["Analyst action", "ALCLS"], "_sharemaestro": {"country": "France", "coverage": "Provider-linked mention", "market_context": null, "companies": [{"symbol": "ALCLS", "name": "Cellectis S.A.", "sentiment_url": "https://sharemaestro.com/sentiment/094ba8d4-1a5b-4ff5-a789-630e49274513/"}]}}, {"id": "source:c484bca261c4a3982a6bcdde85ebbdb5a9c73ae69d053fb4c1a65ad9f7354295", "url": "https://finance.yahoo.com/healthcare/articles/u-physical-therapy-announces-cfo-113000319.html", "external_url": "https://finance.yahoo.com/healthcare/articles/u-physical-therapy-announces-cfo-113000319.html", "title": "U.S. Physical Therapy Announces CFO", "content_text": "HOUSTON, August 14, 2026--(BUSINESS WIRE)--U.S. Physical Therapy, Inc. (\"USPH\" or the \"Company\") (NYSE, NYSE Texas: USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury prevention services (\"IIP\"), today announced that Nchacha Etta will serve as the Company's Executive Vice President and Chief Financial Officer, effective as of September 1, 2026. Jason Curtis, the Company's Senior Vice President, Finance and Accounting, served as Interim CFO since April 24, 2026. Mr. Etta brings significant experience, most recently serving as Executive Vice Presi", "date_published": "2026-08-14T11:30:00+00:00", "authors": [{"name": "finance.yahoo.com"}], "tags": ["Market update", "EL"], "_sharemaestro": {"country": "France", "coverage": "Provider-linked mention", "market_context": null, "companies": [{"symbol": "EL", "name": "EssilorLuxottica Soci\u00e9t\u00e9 anonyme", "sentiment_url": "https://sharemaestro.com/sentiment/a93f9521-4bc1-446c-867a-d3c5322bfdd6/"}]}}, {"id": "source:0900c281a1b7e54999dfd196bbfe90a2a2a5cb52fdbe999e1d2a91793c625390", "url": "https://finance.yahoo.com/healthcare/articles/pfizer-valneva-lyme-disease-vaccine-050000585.html", "external_url": "https://finance.yahoo.com/healthcare/articles/pfizer-valneva-lyme-disease-vaccine-050000585.html", "title": "Pfizer and Valneva\u2019s Lyme Disease Vaccine Candidate Marketing Authorization Application Validated by European Medicines Agency", "content_text": "Submission based on favorable efficacy and safety results from Phase 3 VALOR trial NEW YORK & LYON, France, August 14, 2026--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) and Valneva SE (Nasdaq: VALN; Euronext Paris: VLA) today announced that the European Medicines Agency (EMA) has validated the Marketing Authorization Application (MAA) for PF-07307405, the companies' 6-valent outer surface protein A (OspA)-based Lyme disease vaccine candidate and will begin its assessment of the application. The application is based on encouraging efficacy of more than 70% observed in the Phase 3 VALOR \"Vaccine Ag", "date_published": "2026-08-14T05:00:00+00:00", "authors": [{"name": "finance.yahoo.com"}], "tags": ["Earnings", "VLA"], "_sharemaestro": {"country": "France", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "VLA", "name": "Valneva SE", "sentiment_url": "https://sharemaestro.com/sentiment/29755642-e05f-4073-89cd-1a3af2a51d87/"}]}}, {"id": "source:fa1625d52811a8c2cdf68e6ccbcfdc979c1b312f424d65b9933a6954890be256", "url": "https://finance.yahoo.com/markets/stocks/articles/sanofi-information-concerning-total-number-163400000.html", "external_url": "https://finance.yahoo.com/markets/stocks/articles/sanofi-information-concerning-total-number-163400000.html", "title": "Sanofi: Information concerning the total number of voting rights and shares - July 2026", "content_text": "Sanofi Winthrop Industrie Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code de commerce (the French Commercial Code) and article 223-16 of the R\u00e8glement g\u00e9n\u00e9ral de l'Autorit\u00e9 des March\u00e9s Financiers (Regulation of the French stock market authority) Sanofi a French soci\u00e9t\u00e9 anonyme with a registered share capital of \u20ac2,415,546,786 Registered office : 46, avenue de la Grande Arm\u00e9e - 75017 Paris - France Registered at the Paris Commercial and Companies Registry under number 395 030 844 Date Total number of issued shares Number ", "date_published": "2026-08-13T16:34:00+00:00", "authors": [{"name": "finance.yahoo.com"}], "tags": ["Market update", "SAN"], "_sharemaestro": {"country": "France", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "SAN", "name": "Sanofi", "sentiment_url": "https://sharemaestro.com/sentiment/43fce935-d89d-4a60-883a-3eedb25e8674/"}]}}, {"id": "source:099661ecc0bba4c15ccaa35c84a4fa3d5949068502d3e0f1d3319564d315019c", "url": "https://finance.yahoo.com/markets/world-indices/articles/european-equities-traded-us-rise-151440591.html", "external_url": "https://finance.yahoo.com/markets/world-indices/articles/european-equities-traded-us-rise-151440591.html", "title": "European Equities Traded in the US Rise in Thursday Trading", "content_text": "European equities traded in the US as American depositary receipts were higher late Thursday morning, rising 0.45% to 1,969.72 on the S&P Europe Select ADR Index. From continental Europe, the gainers were led by biopharmaceutical company Cellectis (CLLS) and biotech firm Evaxion Silver Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium news articles. Upgrade now", "date_published": "2026-08-13T15:14:40+00:00", "authors": [{"name": "finance.yahoo.com"}], "tags": ["Analyst action", "ALCLS"], "_sharemaestro": {"country": "France", "coverage": "Provider-linked mention", "market_context": null, "companies": [{"symbol": "ALCLS", "name": "Cellectis S.A.", "sentiment_url": "https://sharemaestro.com/sentiment/094ba8d4-1a5b-4ff5-a789-630e49274513/"}]}}, {"id": "source:85b30a7f57dae1141c5c497a86240aca8d963593b82186f4fc9281f6c0595490", "url": "https://finance.yahoo.com/healthcare/articles/eurofins-cdmo-alphora-expands-kilolab-140000526.html", "external_url": "https://finance.yahoo.com/healthcare/articles/eurofins-cdmo-alphora-expands-kilolab-140000526.html", "title": "Eurofins CDMO Alphora Expands Kilolab and High Potency Development and Manufacturing Capabilities", "content_text": "MISSISSAUGA, Ontario, August 13, 2026--(BUSINESS WIRE)--Eurofins CDMO Alphora has expanded its kilolab and high-potency active pharmaceutical ingredient (HPAPI) development and manufacturing capabilities in Mississauga. The expanded laboratories are designed to support the growing demand for enhanced flexibility as part of process development, scale-up, and manufacturing activities for non-high potent and high potent programs. Together, the suites cover 627 square feet. They are equipped with walk-in fume hoods capable of supporting up to 100L glass reactors and utilise a flexible design so th", "date_published": "2026-08-13T14:00:00+00:00", "authors": [{"name": "finance.yahoo.com"}], "tags": ["Market update", "ERF"], "_sharemaestro": {"country": "France", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "ERF", "name": "Eurofins Scientific SE", "sentiment_url": "https://sharemaestro.com/sentiment/2d685a0f-9634-4818-8e2c-afeec50d9094/"}]}}, {"id": "source:b2b30acb8c06b5f7976cf658d8db7cb75ef996188e43620f614f32c8afcad0e8", "url": "https://finance.yahoo.com/healthcare/articles/aimwellbio-publishes-investor-briefing-acquired-130000812.html", "external_url": "https://finance.yahoo.com/healthcare/articles/aimwellbio-publishes-investor-briefing-acquired-130000812.html", "title": "AimwellBio Publishes Investor Briefing on Acquired Trustr Intellectual Property Portfolio Valued at $10m Reinforcing Commitment to Transparency", "content_text": "Behavioral engagement technology carries documented institutional lineage spanning Oxford, the University of Vermont, Cornell, AMCP, and a Sanofi pilot program, as inventor Dr. Chris A. Jones joins AimwellBio's Board of Advisors and leads further expansion. MIAMI, FL / ACCESS Newswire / August 13, 2026 / Aimwell Partners Inc. (OTC:AIMN) - AimwellBio today announced the availability of a comprehensive investor briefing covering the recently acquired Trustr intellectual property portfolio. The briefing is available to current and prospective investors as part of the Company's commitment to provi", "date_published": "2026-08-13T13:00:00+00:00", "authors": [{"name": "finance.yahoo.com"}], "tags": ["Market update", "SAN"], "_sharemaestro": {"country": "France", "coverage": "Provider-linked mention", "market_context": null, "companies": [{"symbol": "SAN", "name": "Sanofi", "sentiment_url": "https://sharemaestro.com/sentiment/43fce935-d89d-4a60-883a-3eedb25e8674/"}]}}, {"id": "source:942c45952dd093cb334944b97dfa94e7e4b10082fe98774bfe152d7193ea3b67", "url": "https://finance.yahoo.com/markets/stocks/articles/big-tech-drives-credit-risk-103014617.html", "external_url": "https://finance.yahoo.com/markets/stocks/articles/big-tech-drives-credit-risk-103014617.html", "title": "Big Tech Drives Up Credit Risk for Safe Firms With No AI Links", "content_text": "(Bloomberg) -- As a flood of debt sales by US tech companies ripples through the credit market, it seems to be triggering an inadvertent rise in risk metrics for some of the world's safest firms. Most Read from Bloomberg Walter Sells Lakers, Seeks More Cash to Pay Loans Amid DOJ Probe Phoebe Gates Knew Phia Shopping App Took Credit for Sales It Didn't Drive Trump Seeks Immediate Halt to Judge's Penalties in IRS Case Anthropic Said in Talks to Buy Startup Decart for $6 Billion Trump Weighs Call for Capital Gains Tax Cuts as Midterm Boost Strategists at BNP Paribas SA say these moves are a knock", "date_published": "2026-08-13T10:30:14+00:00", "authors": [{"name": "finance.yahoo.com"}], "tags": ["Balance sheet", "SAN"], "_sharemaestro": {"country": "France", "coverage": "Provider-linked mention", "market_context": null, "companies": [{"symbol": "SAN", "name": "Sanofi", "sentiment_url": "https://sharemaestro.com/sentiment/43fce935-d89d-4a60-883a-3eedb25e8674/"}]}}, {"id": "source:7fbcd1fd43abb4f847bc1485b0c3a2b85289eafaacf3930507fe4934a03f5b05", "url": "https://news.google.com/rss/articles/CBMisgFBVV95cUxPZmdZak5XTWs4eS1OLWpXc3luZWROU2I0UzEweEgxM3d2aFlYZjR5ZHUxdGtRbTh0SlU5ZjI5bUdxeWNHRzZ1LTk4YTVHX0Z5dm9FSWREWlp5dUxsLVJJbW1ScTFTb3JYZERvOW9DRFowOVVheVZOWGhoUVc5VGFEWDJpSE9rZDE2dklzRElULTROMFp5Mjd5dnRSTnFiTTR1TVh3b09FOGEtaHgxSzlBQUNR?oc=5", "external_url": "https://news.google.com/rss/articles/CBMisgFBVV95cUxPZmdZak5XTWs4eS1OLWpXc3luZWROU2I0UzEweEgxM3d2aFlYZjR5ZHUxdGtRbTh0SlU5ZjI5bUdxeWNHRzZ1LTk4YTVHX0Z5dm9FSWREWlp5dUxsLVJJbW1ScTFTb3JYZERvOW9DRFowOVVheVZOWGhoUVc5VGFEWDJpSE9rZDE2dklzRElULTROMFp5Mjd5dnRSTnFiTTR1TVh3b09FOGEtaHgxSzlBQUNR?oc=5", "title": "Valneva d\u00e9voile des r\u00e9sultats en baisse comme pr\u00e9vu", "content_text": "Valneva d\u00e9voile des r\u00e9sultats en baisse comme pr\u00e9vu", "date_published": "2026-08-13T09:01:23+00:00", "authors": [{"name": "Zonebourse"}], "tags": ["Market update", "VLA"], "_sharemaestro": {"country": "France", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "VLA", "name": "Valneva SE", "sentiment_url": "https://sharemaestro.com/sentiment/29755642-e05f-4073-89cd-1a3af2a51d87/"}]}}, {"id": "source:2b01ca1fb4082ad003946edd1a168f34758796aeccf23f8dae47ea177ab294c9", "url": "https://seekingalpha.com/news/4632084-valneva-gaap-eps-of-035-revenue-of-6584m-reaffirms-fy-2026?amp%3Butm_medium=referral&amp%3Bfeed_item_type=news", "external_url": "https://seekingalpha.com/news/4632084-valneva-gaap-eps-of-035-revenue-of-6584m-reaffirms-fy-2026?amp%3Butm_medium=referral&amp%3Bfeed_item_type=news", "title": "Valneva GAAP EPS of -\u20ac0.35, revenue of \u20ac65.84M; reaffirms FY 2026", "content_text": "* Valneva press release [https://seekingalpha.com/pr/20617691-valneva-reports-half-year-2026-financial-results-and-provides-corporate-updates] (VALN [https://seekingalpha.com/symbol/VALN]): 1H GAAP EPS of -\u20ac0.35. * Revenue of \u20ac65.84M (-32.5% Y/Y). * Solid cash position of \u20ac121.5 million as of end June 2026. * FINANCIAL OUTLOOK * Despite the continued adverse impact of the geopolitical environment on travel, Valneva reaffirmed its 2026 guidance with expected product sales of \u20ac135 million to \u20ac150 million and total revenues of \u20ac145 million to \u20ac160 million. * Product gross margins are expected to ", "date_published": "2026-08-13T06:05:24+00:00", "authors": [{"name": "seekingalpha.com"}], "tags": ["Earnings", "VLA"], "_sharemaestro": {"country": "France", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "VLA", "name": "Valneva SE", "sentiment_url": "https://sharemaestro.com/sentiment/29755642-e05f-4073-89cd-1a3af2a51d87/"}]}}, {"id": "source:cd43458cb731296f7072733bebb601944bde7b3165366430c94af54a3ae6c0ff", "url": "https://finance.yahoo.com/healthcare/articles/valneva-reports-half-2026-financial-050000261.html", "external_url": "https://finance.yahoo.com/healthcare/articles/valneva-reports-half-2026-financial-050000261.html", "title": "Valneva Reports Half Year 2026 Financial Results and Provides Corporate Updates", "content_text": "VALNEVA SE Total product sales of \u20ac64.0 million In-line with expectations; full-year guidance of \u20ac135 -150 million reaffirmed Solid cash position of \u20ac121.5 million as of end June 2026 Reflects disciplined cash management and proceeds from the recent reserved offering1 Restructuring program implemented with positive P&L and cash flow impacts expected in the second half of the year and beyond Regulatory decisions for Lyme disease vaccine candidate expected in the next twelve months2 Pfizer remains optimistic about obtaining registration for the vaccine candidate3 Lyon (France), August 13, 2026 \u2013", "date_published": "2026-08-13T05:00:00+00:00", "authors": [{"name": "finance.yahoo.com"}], "tags": ["Earnings", "VLA"], "_sharemaestro": {"country": "France", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "VLA", "name": "Valneva SE", "sentiment_url": "https://sharemaestro.com/sentiment/29755642-e05f-4073-89cd-1a3af2a51d87/"}]}}, {"id": "source:3ea6e701ff7683fcac8c3f9bcb8cf44f16546528c61754b8293901a2b441debc", "url": "https://finance.yahoo.com/markets/commodities/articles/latest-global-whey-protein-market-173000212.html", "external_url": "https://finance.yahoo.com/markets/commodities/articles/latest-global-whey-protein-market-173000212.html", "title": "[Latest] Global Whey Protein Market Size/Share Worth USD 26.04 Billion by 2034 at a 7.56% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)", "content_text": "Custom Market Insights [220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global Whey Protein Market size & share revenue was valued at approximately USD 12.58 Billion in 2024 and is expected to reach USD 13.52 Billion in 2025 and is expected to reach around USD 26.04 Billion by 2034, at a CAGR of 7.56% between 2025 and 2034. The key market players listed in the report with their sales, revenues and strategies are Abbott, Alpavit, Arla Foods, Carbery Group, Davisco Foods International, Inc., Fonterra Co-operative Group Lt", "date_published": "2026-08-12T17:30:00+00:00", "authors": [{"name": "finance.yahoo.com"}], "tags": ["Guidance", "SAN"], "_sharemaestro": {"country": "France", "coverage": "Provider-linked mention", "market_context": null, "companies": [{"symbol": "SAN", "name": "Sanofi", "sentiment_url": "https://sharemaestro.com/sentiment/43fce935-d89d-4a60-883a-3eedb25e8674/"}]}}, {"id": "source:003901eac9af269cec5562f97186cf7b5459ffc496c54fb72170db2160dfcb70", "url": "https://finance.yahoo.com/markets/stocks/articles/eurofins-scientific-director-pdmr-shareholding-160000890.html", "external_url": "https://finance.yahoo.com/markets/stocks/articles/eurofins-scientific-director-pdmr-shareholding-160000890.html", "title": "Eurofins Scientific: Director/PDMR Shareholding", "content_text": "LUXEMBOURG, August 12, 2026--(BUSINESS WIRE)--Eurofins Scientific SE (EUFI.PA) has received various notifications of dealing from Persons Discharging Managerial Responsibilities (\"PDMR\"). The notification of Dealing Form for each PDMR can be found below. This notification is made in accordance with the European Market Abuse Regulation. NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM 1. Details of the person discharging managerial responsibilities/person closely associated a) Name Analytical Bioventur", "date_published": "2026-08-12T16:00:00+00:00", "authors": [{"name": "finance.yahoo.com"}], "tags": ["Market update", "ERF"], "_sharemaestro": {"country": "France", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "ERF", "name": "Eurofins Scientific SE", "sentiment_url": "https://sharemaestro.com/sentiment/2d685a0f-9634-4818-8e2c-afeec50d9094/"}]}}, {"id": "source:d05af02cb38f6cffff14bb7f33d49aa5c3c8ef0bff457a7422fe9292d5d4c38c", "url": "https://finance.yahoo.com/markets/stocks/articles/national-vision-raises-outlook-higher-155813048.html", "external_url": "https://finance.yahoo.com/markets/stocks/articles/national-vision-raises-outlook-higher-155813048.html", "title": "National Vision Raises Outlook as Higher-Value Customers Fuel Breakout Quarter", "content_text": "By Karen Roman National Vision Holdings, Inc. (Nasdaq: EYE) said second quarter net revenue increased 2.5% to $498.8 million compared to the year prior and net income was $12.4 million against $8.7 million, with net income margin up to 2.5% from 1.8%. Diluted earnings per share were $0.15 compared to $0.11, and adjusted operating income increased 32.7% to $31.6 million, it stated. The company updated its 2026 fiscal outlook and now adjusted operating income of $119 \u2013 $139 million against a prior target of $107 \u2013 $133 million. READ MORE Once Upon a Farm Lifts 2026 Outlook Again as Q2 Revenue Su", "date_published": "2026-08-12T15:58:13+00:00", "authors": [{"name": "finance.yahoo.com"}], "tags": ["Guidance", "EL"], "_sharemaestro": {"country": "France", "coverage": "Provider-linked mention", "market_context": null, "companies": [{"symbol": "EL", "name": "EssilorLuxottica Soci\u00e9t\u00e9 anonyme", "sentiment_url": "https://sharemaestro.com/sentiment/a93f9521-4bc1-446c-867a-d3c5322bfdd6/"}]}}, {"id": "source:afc9bcae07875098abc4a177934a99f080c6680235bfdb0a9408520e0a6ab43c", "url": "https://finance.yahoo.com/technology/ai/articles/market-chatter-meta-platforms-faces-154235800.html", "external_url": "https://finance.yahoo.com/technology/ai/articles/market-chatter-meta-platforms-faces-154235800.html", "title": "Update: Market Chatter: Meta Platforms Faces German Criminal Complaint Over AI Smart Glasses", "content_text": "(Updates with response from a Meta Platforms spokesperson in the fourth paragraph.) Meta Platform PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium news articles. Upgrade Already have a subscription? Sign in", "date_published": "2026-08-12T15:42:35+00:00", "authors": [{"name": "finance.yahoo.com"}], "tags": ["Analyst action", "EL"], "_sharemaestro": {"country": "France", "coverage": "Provider-linked mention", "market_context": null, "companies": [{"symbol": "EL", "name": "EssilorLuxottica Soci\u00e9t\u00e9 anonyme", "sentiment_url": "https://sharemaestro.com/sentiment/a93f9521-4bc1-446c-867a-d3c5322bfdd6/"}]}}, {"id": "source:46b3f23a3cbbf72aa4fa4eff600d629dac6ffd5d600b532526e1abeb25fd4333", "url": "https://seekingalpha.com/news/4631498-uk-regulator-reaffirms-safety-of-childhood-vaccination?amp%3Butm_medium=referral&amp%3Bfeed_item_type=news", "external_url": "https://seekingalpha.com/news/4631498-uk-regulator-reaffirms-safety-of-childhood-vaccination?amp%3Butm_medium=referral&amp%3Bfeed_item_type=news", "title": "U.K. regulator reaffirms safety of childhood vaccination", "content_text": "[Syringe drawing liquid medication from medical vial] zhikun sun/iStock via Getty Images Days after President Donald Trump ordered major changes to the U.S. childhood immunization schedule, the U.K. drug regulator on Wednesday reaffirmed the safety of pediatric vaccination, noting it remains one of the safest and most effective ways to fight many severe infectious diseases. Issuing an executive order to reduce the number of childhood vaccines administered in the U.S. and split the measles, mumps, and rubella vaccination into three separate shots on Monday, Trump suggested a link between vaccin", "date_published": "2026-08-12T13:13:40+00:00", "authors": [{"name": "seekingalpha.com"}], "tags": ["Market update", "SAN"], "_sharemaestro": {"country": "France", "coverage": "Provider-linked mention", "market_context": null, "companies": [{"symbol": "SAN", "name": "Sanofi", "sentiment_url": "https://sharemaestro.com/sentiment/43fce935-d89d-4a60-883a-3eedb25e8674/"}]}}, {"id": "source:be89b1398602f27533c433b3a0057a49845faf63eef98f29500dc417f924f539", "url": "https://finance.yahoo.com/healthcare/articles/adagene-reports-six-months-2026-113000661.html", "external_url": "https://finance.yahoo.com/healthcare/articles/adagene-reports-six-months-2026-113000661.html", "title": "Adagene Reports Six Months 2026 Financial Results and Provides Corporate Updates", "content_text": "Adagene Inc. Randomized Phase 2 trial in microsatellite stable colorectal cancer (MSS CRC) ongoing, with results expected in 1H 2027; potential registration trial expected in 2027 once recommended dose regimen has been established Data reported at AACR from triple combination therapy in 1L hepatocellular carcinoma (HCC) and late-line MSS CRC highlights muzastotug's potential as a backbone combination treatment for multiple tumor types across all lines of therapy Initiated dosing in a global Phase 1/2 basket trial evaluating muzastotug in combination with a next-generation investigational IO ag", "date_published": "2026-08-12T11:30:00+00:00", "authors": [{"name": "finance.yahoo.com"}], "tags": ["Regulatory and legal", "SAN"], "_sharemaestro": {"country": "France", "coverage": "Provider-linked mention", "market_context": null, "companies": [{"symbol": "SAN", "name": "Sanofi", "sentiment_url": "https://sharemaestro.com/sentiment/43fce935-d89d-4a60-883a-3eedb25e8674/"}]}}, {"id": "source:a98bf40dc28964028c314674c98bb3ba67f672de930dcedcae5839f480c10811", "url": "https://finance.yahoo.com/healthcare/articles/indupro-closes-77-million-series-113000456.html", "external_url": "https://finance.yahoo.com/healthcare/articles/indupro-closes-77-million-series-113000456.html", "title": "InduPro Closes $77 Million Series B Financing and Doses First Patient in Phase 1 Study of Lead Oncology Program IDP-001", "content_text": "IDP-001 is a bispecific antibody-drug conjugate targeting EGFR and a novel Tumor-Associated Proximity Antigen identified through InduPro's proximity-guided platform Phase 1 study is enrolling adults with advanced squamous non-small cell lung cancer and other solid tumors Financing led by The Column Group, with participation from Vida Ventures, MRL Ventures Fund, Emerson Collective (advised by Yosemite), Euclidean Capital, Solasta Ventures, Sanofi, and Eli Lilly and Company SEATTLE & CAMBRIDGE, Mass., August 12, 2026--(BUSINESS WIRE)--InduPro, Inc., a biotechnology company defining membrane pro", "date_published": "2026-08-12T11:30:00+00:00", "authors": [{"name": "finance.yahoo.com"}], "tags": ["Market update", "SAN"], "_sharemaestro": {"country": "France", "coverage": "Provider-linked mention", "market_context": null, "companies": [{"symbol": "SAN", "name": "Sanofi", "sentiment_url": "https://sharemaestro.com/sentiment/43fce935-d89d-4a60-883a-3eedb25e8674/"}]}}, {"id": "source:03fdb7a288edfc21b40514616b180e7d9df53c218807c001e9d74b6a285253d5", "url": "https://finance.yahoo.com/healthcare/articles/profitable-rare-disease-prize-might-132039632.html", "external_url": "https://finance.yahoo.com/healthcare/articles/profitable-rare-disease-prize-might-132039632.html", "title": "A Profitable Rare-Disease Prize: Who Might Snap Up BioCryst?", "content_text": "Quick Read BioCryst hit its first full year of profitability in 2025, with Q2 2026 revenue up 34% to $218 million, fueling acquisition speculation. Takeda (TAK) tops the buyer rankings as navenibart directly threatens its Takhzyro franchise; AstraZeneca (AZN) ranks second through its Alexion rare-disease platform. Act now: the analyst who called NVIDIA in 2010 just named his top 10 AI stocks \u2014 and BioCryst Pharmaceuticals didn't make the cut. Grab the names FREE today. BioCryst Pharmaceuticals (NASDAQ:BCRX) closed at $9.84 on August 10, 2026, giving the Durham-based rare-disease specialist a m", "date_published": "2026-08-11T13:20:39+00:00", "authors": [{"name": "finance.yahoo.com"}], "tags": ["Deals and strategy", "SAN"], "_sharemaestro": {"country": "France", "coverage": "Provider-linked mention", "market_context": null, "companies": [{"symbol": "SAN", "name": "Sanofi", "sentiment_url": "https://sharemaestro.com/sentiment/43fce935-d89d-4a60-883a-3eedb25e8674/"}]}}, {"id": "source:db8d0c8a8a9dadd63290225c64e6e3e3b8a099c0d212c0ba5e4b0aa0db35bde0", "url": "https://finance.yahoo.com/healthcare/articles/why-amlitelimab-setback-isn-t-232940996.html", "external_url": "https://finance.yahoo.com/healthcare/articles/why-amlitelimab-setback-isn-t-232940996.html", "title": "Why the Amlitelimab Setback Isn\u2019t Enough to Sink Sanofi\u2019s Multi-Billion Dollar Engine", "content_text": "It was reported on July 24 that Sanofi (NASDAQ:SNY) shares underperformed in European trading following the company's decision to drop the clinical development of its eczema candidate, amlitelimab, for moderate-to-severe atopic dermatitis. Rather than a fundamental breakdown, the move reflects an aggressive R&D pipeline review under CEO Bel\u00e9n Garijo, who chose to pull the plug after efficacy and safety data failed to support global regulatory submissions. For a mega-cap pharmaceutical giant like Sanofi, valued at more than $100 billion, abandoning a zero-revenue clinical trial asset is a neces", "date_published": "2026-08-10T23:29:40+00:00", "authors": [{"name": "finance.yahoo.com"}], "tags": ["Earnings", "SAN"], "_sharemaestro": {"country": "France", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "SAN", "name": "Sanofi", "sentiment_url": "https://sharemaestro.com/sentiment/43fce935-d89d-4a60-883a-3eedb25e8674/"}]}}, {"id": "source:637ae3f755f5659fb572113435a99f0d27c2f1ced5e62791268a28fc05a15dec", "url": "https://finance.yahoo.com/healthcare/articles/nurix-therapeutics-apos-stat6-degrader-164414074.html", "external_url": "https://finance.yahoo.com/healthcare/articles/nurix-therapeutics-apos-stat6-degrader-164414074.html", "title": "Nurix Therapeutics' STAT6 Degrader Likely to Receive Increased Recognition, RBC Says", "content_text": "Nurix Therapeutics' (NRIX) STAT6 degrader NX-3911 is likely to receive increased recognition after advancing into clinical development under its collaboration with Sanofi (SNY), RBC Capital Markets said in a Monday research note.The investment firm said limited preclinical data Silver Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium news articles. Upgrade now", "date_published": "2026-08-10T16:44:14+00:00", "authors": [{"name": "finance.yahoo.com"}], "tags": ["Analyst action", "SAN"], "_sharemaestro": {"country": "France", "coverage": "Provider-linked mention", "market_context": null, "companies": [{"symbol": "SAN", "name": "Sanofi", "sentiment_url": "https://sharemaestro.com/sentiment/43fce935-d89d-4a60-883a-3eedb25e8674/"}]}}, {"id": "source:221af0f442ac4426ce134777102e96d5178fde1fb33848fe558e0ac4bc954dd0", "url": "https://finance.yahoo.com/markets/stocks/articles/ipsen-buy-back-programme-art-160000610.html", "external_url": "https://finance.yahoo.com/markets/stocks/articles/ipsen-buy-back-programme-art-160000610.html", "title": "IPSEN - Buy-back programme - Art 5 of MAR - Week 32 - 2026", "content_text": "Ipsen Pharma Aggregated presentation by day and by market Weekly report on share repurchases from 04th August to 05th August 2026 Name of the Issuer Identify code of the Issuer Transaction day Identify code of the financial instrument Total daily volume (in number of shares) Daily weighted average purchase price of the shares Market (MIC Code) IPSEN 549300M6SGDPB4Z94P11 04/08/2026 FR0010259150 10 250 156,7509 XPAR IPSEN 549300M6SGDPB4Z94P11 05/08/2026 FR0010259150 4 383 158,0699 XPAR IPSEN 549300M6SGDPB4Z94P11 05/08/2026 FR0010259150 384 158,2146 AQEU IPSEN 549300M6SGDPB4Z94P11 05/08/2026 FR00", "date_published": "2026-08-10T16:00:00+00:00", "authors": [{"name": "finance.yahoo.com"}], "tags": ["Market update", "IPN"], "_sharemaestro": {"country": "France", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "IPN", "name": "Ipsen S.A.", "sentiment_url": "https://sharemaestro.com/sentiment/65f88221-14dc-4a11-8ddc-81fbb9b05a84/"}]}}, {"id": "source:5818ef853474232e6c61f0a1f12e526b9b96cbcdb99063ae6e75eca3141d2f88", "url": "https://finance.yahoo.com/markets/stocks/articles/eurofins-scientific-se-weekly-report-154500724.html", "external_url": "https://finance.yahoo.com/markets/stocks/articles/eurofins-scientific-se-weekly-report-154500724.html", "title": "Eurofins Scientific SE: Weekly Report on Share Repurchases from 03rd August to 07th August 2026", "content_text": "LUXEMBOURG, August 10, 2026--(BUSINESS WIRE)--Regulatory News: Eurofins Scientific SE (Paris:ERF): Name of the Issuer Identify code of the Issuer Transaction day Identify code of the financial instrument Total daily volume (in number of shares) Daily weighted average purchase price of the shares Market (MIC Code) EUROFINS SCIENTIFIC 529900JEHFM47DYY3S57 03/08/2026 FR0014000MR3 20 000 68.4085 XPAR EUROFINS SCIENTIFIC 529900JEHFM47DYY3S57 04/08/2026 FR0014000MR3 20 000 68.6892 XPAR EUROFINS SCIENTIFIC 529900JEHFM47DYY3S57 05/08/2026 FR0014000MR3 20 000 69.4244 XPAR EUROFINS SCIENTIFIC 529900JEHF", "date_published": "2026-08-10T15:45:00+00:00", "authors": [{"name": "finance.yahoo.com"}], "tags": ["Capital return", "ERF"], "_sharemaestro": {"country": "France", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "ERF", "name": "Eurofins Scientific SE", "sentiment_url": "https://sharemaestro.com/sentiment/2d685a0f-9634-4818-8e2c-afeec50d9094/"}]}}, {"id": "source:7d42e5de72d8e05ded5a67927f837f9d18ccae9f4339f1e05381a1c970df3cf4", "url": "https://finance.yahoo.com/markets/stocks/articles/eurofins-scientific-se-disclosure-total-130700997.html", "external_url": "https://finance.yahoo.com/markets/stocks/articles/eurofins-scientific-se-disclosure-total-130700997.html", "title": "Eurofins Scientific SE: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital at 31 July 2026", "content_text": "LUXEMBOURG, August 10, 2026--(BUSINESS WIRE)--Regulatory News: Eurofins (Paris:ERF): ANNEXE B Form to be used for the disclosure of the total number of voting rights and capital, in accordance with the law and grand-ducal regulation of 11 January 2008 on transparency requirements for issuers of securities 1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedi (including the issuer ID allocated by the CSSF) EUROFINS SCIENTIFIC SE \u2013 E1013 2. Identity of the notifier (if another person makes the notification on behalf of the issuer) N/A 3. Total", "date_published": "2026-08-10T13:07:00+00:00", "authors": [{"name": "finance.yahoo.com"}], "tags": ["Capital return", "ERF"], "_sharemaestro": {"country": "France", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "ERF", "name": "Eurofins Scientific SE", "sentiment_url": "https://sharemaestro.com/sentiment/2d685a0f-9634-4818-8e2c-afeec50d9094/"}]}}, {"id": "source:34e4d37b4046b73310198faa81d3b6b3467b89da134ee73028afed440504502e", "url": "https://finance.yahoo.com/healthcare/articles/novavax-nvax-8-6-beating-101004083.html", "external_url": "https://finance.yahoo.com/healthcare/articles/novavax-nvax-8-6-beating-101004083.html", "title": "Novavax (NVAX) Is Up 8.6% After Beating Q2 Estimates And Expanding Big-Pharma Partnerships - What's Changed", "content_text": "In early August 2026, Novavax reported Q2 2026 revenue of US$56.7 million, sharply lower than the prior year, and moved from net income to a net loss of US$53.39 million, translating into basic and diluted losses of US$0.32 per share from continuing operations. Alongside the weak year-on-year comparisons, Novavax beat analyst expectations for both revenue and earnings and highlighted progress on high-profile partnerships, including Sanofi and Pfizer, while also filing an US$82.47 million employee stock offering shelf registration. Now we'll examine how this mix of better-than-expected Q2 resul", "date_published": "2026-08-08T10:10:04+00:00", "authors": [{"name": "finance.yahoo.com"}], "tags": ["Earnings", "SAN"], "_sharemaestro": {"country": "France", "coverage": "Provider-linked mention", "market_context": null, "companies": [{"symbol": "SAN", "name": "Sanofi", "sentiment_url": "https://sharemaestro.com/sentiment/43fce935-d89d-4a60-883a-3eedb25e8674/"}]}}, {"id": "source:46787fb43fe73f7e7390fa5f3aae1fa0da22c04a8b1f8bf3b58143c57aa7f38c", "url": "https://finance.yahoo.com/healthcare/articles/nvax-q2-earnings-sales-beat-181800274.html", "external_url": "https://finance.yahoo.com/healthcare/articles/nvax-q2-earnings-sales-beat-181800274.html", "title": "NVAX Q2 Earnings & Sales Beat Estimates, '26 Sales Outlook Raised", "content_text": "Novavax NVAX incurred a loss of 32 cents per share in the second quarter of 2026, narrower than the Zacks Consensus Estimate of a loss of 36 cents. In the year-ago quarter, the company had recorded earnings per share (EPS) of 62 cents, driven by milestone-related payments. Quarterly revenues totaled $56.7 million, down 76% year over year. Yet, this metric beat the Zacks Consensus Estimate of $50 million. Shares of Novavax have increased 14% so far this year compared with the industry's 4% growth.Zacks Investment Research Image Source: Zacks Investment Research NVAX's Revenue Mix Shifts Toward ", "date_published": "2026-08-07T18:18:00+00:00", "authors": [{"name": "finance.yahoo.com"}], "tags": ["Earnings", "SAN"], "_sharemaestro": {"country": "France", "coverage": "Provider-linked mention", "market_context": null, "companies": [{"symbol": "SAN", "name": "Sanofi", "sentiment_url": "https://sharemaestro.com/sentiment/43fce935-d89d-4a60-883a-3eedb25e8674/"}]}}, {"id": "source:307f43321619c135d39b3e40963d77556cce3505374cd0a04bb5617626ce7174", "url": "https://news.google.com/rss/articles/CBMiXEFVX3lxTFBUb1dLR2d4Z3h3WjkyTl9kanFRZEtSUTdZTzhpSVZNM0IzNnV6U1p4RlJnczZYa3BEd1pGdkprdnRWcDFOdTljOHNfY1I2WnQwa09lQ3ZFaVR2cHFU?oc=5", "external_url": "https://news.google.com/rss/articles/CBMiXEFVX3lxTFBUb1dLR2d4Z3h3WjkyTl9kanFRZEtSUTdZTzhpSVZNM0IzNnV6U1p4RlJnczZYa3BEd1pGdkprdnRWcDFOdTljOHNfY1I2WnQwa09lQ3ZFaVR2cHFU?oc=5", "title": "R\u00e9sultats de EMEIS", "content_text": "R\u00e9sultats de EMEIS", "date_published": "2026-07-30T07:00:00+00:00", "authors": [{"name": "Investing.com France"}], "tags": ["Market update", "EMEIS"], "_sharemaestro": {"country": "France", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "EMEIS", "name": "EMEIS", "sentiment_url": "https://sharemaestro.com/sentiment/b13920d9-ca13-4f45-96b3-e38b406d4f9d/"}]}}, {"id": "source:9d4b37a43394e8be743c2840a92d118e3bedc93b1aeab7e6f006e82515fa20d8", "url": "https://news.google.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?oc=5", "external_url": "https://news.google.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?oc=5", "title": "\u00ab Notre chiffre d\u2019affaires devrait progresser d\u2019environ 10 % en 2026 \u00bb, Bel\u00e9n Garijo, la nouvelle dirigeante de Sanofi revoit \u00e0 la hausse les pr\u00e9visions du groupe et poursuit la revue du pipeline", "content_text": "\u00ab Notre chiffre d\u2019affaires devrait progresser d\u2019environ 10 % en 2026 \u00bb, Bel\u00e9n Garijo, la nouvelle dirigeante de Sanofi revoit \u00e0 la hausse les pr\u00e9visions du groupe et poursuit la revue du pipeline", "date_published": "2026-07-30T07:00:00+00:00", "authors": [{"name": "L'Usine Nouvelle"}], "tags": ["Market update", "SAN"], "_sharemaestro": {"country": "France", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "SAN", "name": "Sanofi", "sentiment_url": "https://sharemaestro.com/sentiment/43fce935-d89d-4a60-883a-3eedb25e8674/"}]}}, {"id": "source:8cbdeba03ccf7367784e16538e35587715235b038ef4da266bc15fe5e66bdb33", "url": "https://news.google.com/rss/articles/CBMi4AFBVV95cUxQYVBlak4xbXdpNkVXRWxxcTRETkI3ZEhyajh6MExIUEZIM29jMDNqUzhUcEdwbnhqN251U1J1dnpXVkRrWi0tQ3hpa1lPYS1qdkNGajlaZml1M2pFQm9tT29JXzU5dHEwMmpZbC1RajQyVXBoa2c1VGRDdlpIMmxBZUEwVS1jNmhqMmZLSnh2eDA1LTYwdTJabWJkWlNVek1zSklQZFpzajJEQU9lamViYkNQNEotelhXUV8xVE54UnlVSkwxNFNnYWVEZlZjRnFzcGRTQmVHdjF3RVBOZHN3RQ?oc=5", "external_url": "https://news.google.com/rss/articles/CBMi4AFBVV95cUxQYVBlak4xbXdpNkVXRWxxcTRETkI3ZEhyajh6MExIUEZIM29jMDNqUzhUcEdwbnhqN251U1J1dnpXVkRrWi0tQ3hpa1lPYS1qdkNGajlaZml1M2pFQm9tT29JXzU5dHEwMmpZbC1RajQyVXBoa2c1VGRDdlpIMmxBZUEwVS1jNmhqMmZLSnh2eDA1LTYwdTJabWJkWlNVek1zSklQZFpzajJEQU9lamViYkNQNEotelhXUV8xVE54UnlVSkwxNFNnYWVEZlZjRnFzcGRTQmVHdjF3RVBOZHN3RQ?oc=5", "title": "Inventiva annonce ses r\u00e9sultats financiers pr\u00e9liminaires pour le premier semestre 2026\u00b9", "content_text": "Inventiva annonce ses r\u00e9sultats financiers pr\u00e9liminaires pour le premier semestre 2026\u00b9", "date_published": "2026-07-29T20:00:07+00:00", "authors": [{"name": "Zonebourse"}], "tags": ["Market update", "IVA"], "_sharemaestro": {"country": "France", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "IVA", "name": "Inventiva S.A.", "sentiment_url": "https://sharemaestro.com/sentiment/5468d44e-7106-4c2a-bb53-f659e64725be/"}]}}, {"id": "source:8e6649c23ffde1086c2dcd43b223097d25c0f5575848c8eecbd712a399950aaa", "url": "https://news.google.com/rss/articles/CBMidkFVX3lxTE1uLUZYdTB5MVNrWUxkd3Z2U2xPVFotU3ZNZDlycmdWS21hUWFkT2taQnRJb0stSGlWcmRhLTJ4MnZwNjNNbHhEMU4ta3RRRHpwX05QYUpSZW5aX2Vndk9CbC13Qi1mQW1VZnBVRU13cmQxdzhBeEE?oc=5", "external_url": "https://news.google.com/rss/articles/CBMidkFVX3lxTE1uLUZYdTB5MVNrWUxkd3Z2U2xPVFotU3ZNZDlycmdWS21hUWFkT2taQnRJb0stSGlWcmRhLTJ4MnZwNjNNbHhEMU4ta3RRRHpwX05QYUpSZW5aX2Vndk9CbC13Qi1mQW1VZnBVRU13cmQxdzhBeEE?oc=5", "title": "Valneva SE: Objectif de Cours et Consensus des Analystes | VLA | FR0004056851", "content_text": "Valneva SE: Objectif de Cours et Consensus des Analystes | VLA | FR0004056851", "date_published": "2026-06-30T07:00:00+00:00", "authors": [{"name": "Zonebourse"}], "tags": ["Market update", "VLA"], "_sharemaestro": {"country": "France", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "VLA", "name": "Valneva SE", "sentiment_url": "https://sharemaestro.com/sentiment/29755642-e05f-4073-89cd-1a3af2a51d87/"}]}}, {"id": "source:727e5e44de211f72927cbecd5fec88007266281fac58f6b4e840effa5270965d", "url": "https://news.google.com/rss/articles/CBMifEFVX3lxTE9HTTNnNkYzNW5HdzRicllFWnJMWnVvSWVZTXhwV0xBM3ZNMWh3X3J1NllXX1BqVjhlM29ITXV2TUtXZ2hnSGI5dEpqdjhicTd1M2ZZYmlheVVSYXJUb0hxeEJDN19PV0J2Rm9VUWtUcWo4NUd4c1BaTkxPX3Q?oc=5", "external_url": "https://news.google.com/rss/articles/CBMifEFVX3lxTE9HTTNnNkYzNW5HdzRicllFWnJMWnVvSWVZTXhwV0xBM3ZNMWh3X3J1NllXX1BqVjhlM29ITXV2TUtXZ2hnSGI5dEpqdjhicTd1M2ZZYmlheVVSYXJUb0hxeEJDN19PV0J2Rm9VUWtUcWo4NUd4c1BaTkxPX3Q?oc=5", "title": "ALCLS Pr\u00e9visions - Objectif de prix pour 2027", "content_text": "ALCLS Pr\u00e9visions - Objectif de prix pour 2027", "date_published": "2026-06-26T23:29:10+00:00", "authors": [{"name": "TradingView"}], "tags": ["Market update", "ALCLS"], "_sharemaestro": {"country": "France", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "ALCLS", "name": "Cellectis S.A.", "sentiment_url": "https://sharemaestro.com/sentiment/094ba8d4-1a5b-4ff5-a789-630e49274513/"}]}}, {"id": "source:8e4c5980334391a4928cbb3008632992faabfd1c09714a43bf438bfbc2f793a2", "url": "https://news.google.com/rss/articles/CBMifEFVX3lxTE12SWZMSVZzUTlaa1d1MjBHaGpRVTJyb1Y3WGVjZXZQQWxXbU92RlZ1UWRnbXJGNlRkTTlvQkVJYW9EbkFEQkNxMHNobGFmWVltZkFpMkRadmYyOEloWjVKcHl2eVZ2eEdTZHlzZ2stQTBOTjdkNFJTaTdYalA?oc=5", "external_url": "https://news.google.com/rss/articles/CBMifEFVX3lxTE12SWZMSVZzUTlaa1d1MjBHaGpRVTJyb1Y3WGVjZXZQQWxXbU92RlZ1UWRnbXJGNlRkTTlvQkVJYW9EbkFEQkNxMHNobGFmWVltZkFpMkRadmYyOEloWjVKcHl2eVZ2eEdTZHlzZ2stQTBOTjdkNFJTaTdYalA?oc=5", "title": "MEDCL Pr\u00e9visions - Objectif de prix pour 2027", "content_text": "MEDCL Pr\u00e9visions - Objectif de prix pour 2027", "date_published": "2026-06-26T23:25:21+00:00", "authors": [{"name": "TradingView"}], "tags": ["Market update", "MEDCL"], "_sharemaestro": {"country": "France", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "MEDCL", "name": "MedinCell S.A.", "sentiment_url": "https://sharemaestro.com/sentiment/c1a6a004-ed02-43d9-a6ea-21f7d30551c3/"}]}}, {"id": "source:3cfc9f7302f325f3ac5b27df024094bce3b89eb1581b1b4d1fc9984e1b71572c", "url": "https://news.google.com/rss/articles/CBMie0FVX3lxTFBXQUJ3RVVzZWZDdEZlLU11WlU2VHJEdTEtUmdzY0pBeDE5dTZhNFlkalZ3MXpUOTVuWTlqV3FBR0pyQ0VfdXZobElRODFZT1lKU09Rdk5ydm1iaEMtT20tM2lzbDZ1TGZFcmM1MnBOU0Z6NGQxeFAxRHdCUQ?oc=5", "external_url": "https://news.google.com/rss/articles/CBMie0FVX3lxTFBXQUJ3RVVzZWZDdEZlLU11WlU2VHJEdTEtUmdzY0pBeDE5dTZhNFlkalZ3MXpUOTVuWTlqV3FBR0pyQ0VfdXZobElRODFZT1lKU09Rdk5ydm1iaEMtT20tM2lzbDZ1TGZFcmM1MnBOU0Z6NGQxeFAxRHdCUQ?oc=5", "title": "ABVX Pr\u00e9visions - Objectif de prix pour 2027", "content_text": "ABVX Pr\u00e9visions - Objectif de prix pour 2027", "date_published": "2026-06-25T11:57:52+00:00", "authors": [{"name": "TradingView"}], "tags": ["Market update", "ABVX"], "_sharemaestro": {"country": "France", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "ABVX", "name": "ABIVAX Soci\u00e9t\u00e9 Anonyme", "sentiment_url": "https://sharemaestro.com/sentiment/31eb5de8-5e84-4e38-ba2e-0b160353627c/"}]}}, {"id": "source:b8c0dbb7dee782158233055ca0d834042267a52211d88316d3c52797acc9baf8", "url": "https://news.google.com/rss/articles/CBMiZ0FVX3lxTE55QWdmd1psLVZCTW9DNUZRZTBxbjVPRG5WWW04LVM4UmpqOFV5bW1DdXNtUUZRVldmNjFHcm5BMFJXeHF4UUI3eDRndnlRYjhzSzAtQlpjdVlpdWNNWXFCTFg3WjEwZHM?oc=5", "external_url": "https://news.google.com/rss/articles/CBMiZ0FVX3lxTE55QWdmd1psLVZCTW9DNUZRZTBxbjVPRG5WWW04LVM4UmpqOFV5bW1DdXNtUUZRVldmNjFHcm5BMFJXeHF4UUI3eDRndnlRYjhzSzAtQlpjdVlpdWNNWXFCTFg3WjEwZHM?oc=5", "title": "Aelis Farma : Mise \u00e0 disposition du descriptif du programme de rachat d\u2019actions", "content_text": "Aelis Farma : Mise \u00e0 disposition du descriptif du programme de rachat d\u2019actions", "date_published": "2026-06-22T07:00:00+00:00", "authors": [{"name": "Business Wire"}], "tags": ["Market update", "AELIS"], "_sharemaestro": {"country": "France", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "AELIS", "name": "Aelis Farma SA", "sentiment_url": "https://sharemaestro.com/sentiment/f76a96b8-fae1-4e23-a5bf-bc0d22f21b87/"}]}}, {"id": "source:b084dbdf731a9af7cee0ed96e3411660edb4ffdda765a69866f0ebafb2c51a59", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxPLWZmUlpiY2pwUHpoVGlHSmgtQ0JoaVk3T2hrMUZUTzBHR2ltVXVyMzNxWFBMNF9RMDh6aTRweUU2YktXLVZUY2ZJSklkR0FvQU1EekJmenRxTTU1dHFybk5IbnlfZFBrRUwzb05Qb01BS29WZ040cjRCeDJVSHVqWkxIaWNGaUJTNlRXTG5kX1dhOVU5OGlJNy1EYmxtZlc0dFVTWmFxU2htQlF1TnN3VnA3UkU?oc=5", "external_url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxPLWZmUlpiY2pwUHpoVGlHSmgtQ0JoaVk3T2hrMUZUTzBHR2ltVXVyMzNxWFBMNF9RMDh6aTRweUU2YktXLVZUY2ZJSklkR0FvQU1EekJmenRxTTU1dHFybk5IbnlfZFBrRUwzb05Qb01BS29WZ040cjRCeDJVSHVqWkxIaWNGaUJTNlRXTG5kX1dhOVU5OGlJNy1EYmxtZlc0dFVTWmFxU2htQlF1TnN3VnA3UkU?oc=5", "title": "Medincell en forte baisse apr\u00e8s les r\u00e9sultats annuels", "content_text": "Medincell en forte baisse apr\u00e8s les r\u00e9sultats annuels", "date_published": "2026-06-17T07:00:00+00:00", "authors": [{"name": "Zonebourse"}], "tags": ["Market update", "MEDCL"], "_sharemaestro": {"country": "France", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "MEDCL", "name": "MedinCell S.A.", "sentiment_url": "https://sharemaestro.com/sentiment/c1a6a004-ed02-43d9-a6ea-21f7d30551c3/"}]}}, {"id": "source:90cad6becbbc95802779733e788bc7cbf41c447fa0db58056fef514f3eb60c49", "url": "https://news.google.com/rss/articles/CBMijwFBVV95cUxPVmZ2M0dkakpyZ2ZCZm93U3RHODNlemdpYkdJRzFVclljSkR1VUFXa0UtSW1ISmhIV092c1FUMDNnaUJPNXU2OEdCTlptejBQUFk4dXRXVVFjMWtrTWtXS2h0REZleDNKTTl5enVoc0NQa0h6bVhuNEtkaHNTRTd3bEhEY282cUJfRWVLVDR2NA?oc=5", "external_url": "https://news.google.com/rss/articles/CBMijwFBVV95cUxPVmZ2M0dkakpyZ2ZCZm93U3RHODNlemdpYkdJRzFVclljSkR1VUFXa0UtSW1ISmhIV092c1FUMDNnaUJPNXU2OEdCTlptejBQUFk4dXRXVVFjMWtrTWtXS2h0REZleDNKTTl5enVoc0NQa0h6bVhuNEtkaHNTRTd3bEhEY282cUJfRWVLVDR2NA?oc=5", "title": "Valneva chute puis remonte apr\u00e8s ses r\u00e9sultats T1", "content_text": "Valneva chute puis remonte apr\u00e8s ses r\u00e9sultats T1", "date_published": "2026-05-13T07:00:00+00:00", "authors": [{"name": "XTB.com"}], "tags": ["Market update", "VLA"], "_sharemaestro": {"country": "France", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "VLA", "name": "Valneva SE", "sentiment_url": "https://sharemaestro.com/sentiment/29755642-e05f-4073-89cd-1a3af2a51d87/"}]}}, {"id": "source:0dfe2a1cf5db58a5c3175c0dc1cdf3625ab183977b766ff7550ad3f5c7825a01", "url": "https://news.google.com/rss/articles/CBMi3AFBVV95cUxPa0hZc29LaXJPa0NfR1pkM1UyYW9oMmF0c3owSkNIckYtMmZqNjM0a3k5dDJ2VDQtZEJVVk83RDAxaE5LWkdZZU1henlCWGZjN3oxRVZhYkg5anRqdV9PcHE0ZnVMc25KOVNHbjh3TmpmLUxHUGp5VmZBeVZFVjFWZmg4dEJhTktVQnh6T3ZpaXJyUktEWjVWOC0xTHplSzl2YjdHUkk0eUNULTRueWJybFZMVW5WeTRwODAtRUZVQ1F3eC1mT2NjeTV0OGtxSmY1NkpqSFpNajNIc3RE?oc=5", "external_url": "https://news.google.com/rss/articles/CBMi3AFBVV95cUxPa0hZc29LaXJPa0NfR1pkM1UyYW9oMmF0c3owSkNIckYtMmZqNjM0a3k5dDJ2VDQtZEJVVk83RDAxaE5LWkdZZU1henlCWGZjN3oxRVZhYkg5anRqdV9PcHE0ZnVMc25KOVNHbjh3TmpmLUxHUGp5VmZBeVZFVjFWZmg4dEJhTktVQnh6T3ZpaXJyUktEWjVWOC0xTHplSzl2YjdHUkk0eUNULTRueWJybFZMVW5WeTRwODAtRUZVQ1F3eC1mT2NjeTV0OGtxSmY1NkpqSFpNajNIc3RE?oc=5", "title": "Action Valneva : le titre touche sa r\u00e9sistance apr\u00e8s la publication du chiffre d'affaires 2025", "content_text": "Action Valneva : le titre touche sa r\u00e9sistance apr\u00e8s la publication du chiffre d'affaires 2025", "date_published": "2026-02-20T08:00:00+00:00", "authors": [{"name": "Id\u00e9al Investisseur"}], "tags": ["Market update", "VLA"], "_sharemaestro": {"country": "France", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "VLA", "name": "Valneva SE", "sentiment_url": "https://sharemaestro.com/sentiment/29755642-e05f-4073-89cd-1a3af2a51d87/"}]}}, {"id": "source:d9049936100ed384ec28833fb80acbb4a06e4c57c61bd575e72343f336edc8e4", "url": "https://news.google.com/rss/articles/CBMiekFVX3lxTE1Xb2M5LWl5ZVFmUGN5STFsTU5HQUprMmZUYlRWbXdXZ1JtSjR4UWYzVHctYlhBdEJZcHBDMGd1cUw5YW5zWnItMzJVZ25rQnJMVGVROW9tNXpsOXd1RXlxLXowSFJIWXBWdHBQSUhxcVhfV2J5bXhldWNR?oc=5", "external_url": "https://news.google.com/rss/articles/CBMiekFVX3lxTE1Xb2M5LWl5ZVFmUGN5STFsTU5HQUprMmZUYlRWbXdXZ1JtSjR4UWYzVHctYlhBdEJZcHBDMGd1cUw5YW5zWnItMzJVZ25rQnJMVGVROW9tNXpsOXd1RXlxLXowSFJIWXBWdHBQSUhxcVhfV2J5bXhldWNR?oc=5", "title": "R\u00e9sultats de EssilorLuxottica", "content_text": "R\u00e9sultats de EssilorLuxottica", "date_published": "2026-02-12T08:00:00+00:00", "authors": [{"name": "Morningstar"}], "tags": ["Market update", "EL"], "_sharemaestro": {"country": "France", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "EL", "name": "EssilorLuxottica Soci\u00e9t\u00e9 anonyme", "sentiment_url": "https://sharemaestro.com/sentiment/a93f9521-4bc1-446c-867a-d3c5322bfdd6/"}]}}, {"id": "source:b0f4ee570670cf91ff67146573504531fa848e8c34ae9d1d27953b0b47b0081b", "url": "https://news.google.com/rss/articles/CBMitAJBVV95cUxQaHhUX0J2UXowTHBpeHRMbmlsVDRBdVhQeThzVFZzYlZhaHpRMC1kS1M0X1pRTUpuMUtENkNMdzh6M1E1QjVCRlI5Mnp2VFVaNENUdFF1dlhpU2FEU25oOFowai1CVlh1cHlZM3ByMXpOZDVtWGFlWjFoSmZ4ekMzNk0tcnBIQ095OGxNMmNFeEQwdmhHSXRldVh3bnphOVIxenVpakZfY0pSa1BpWGZHSmNxLUlIX2Roc2Q2N3c1QUFEMC1CTVRlckY5SmhlcW96MDdQVGRfT0NFR094VTNoeU1aRWpJTGJlRFJIUTJ0czBLc0s5QTIyV0N2VHhFWWQ1Nzh3ZjU0TlhLQ0xZZWR6SnlEU2lHNWpOejUwTGZKN3JxMS1BSlpfRnlZVXBLVHpqX09wcw?oc=5", "external_url": "https://news.google.com/rss/articles/CBMitAJBVV95cUxQaHhUX0J2UXowTHBpeHRMbmlsVDRBdVhQeThzVFZzYlZhaHpRMC1kS1M0X1pRTUpuMUtENkNMdzh6M1E1QjVCRlI5Mnp2VFVaNENUdFF1dlhpU2FEU25oOFowai1CVlh1cHlZM3ByMXpOZDVtWGFlWjFoSmZ4ekMzNk0tcnBIQ095OGxNMmNFeEQwdmhHSXRldVh3bnphOVIxenVpakZfY0pSa1BpWGZHSmNxLUlIX2Roc2Q2N3c1QUFEMC1CTVRlckY5SmhlcW96MDdQVGRfT0NFR094VTNoeU1aRWpJTGJlRFJIUTJ0czBLc0s5QTIyV0N2VHhFWWQ1Nzh3ZjU0TlhLQ0xZZWR6SnlEU2lHNWpOejUwTGZKN3JxMS1BSlpfRnlZVXBLVHpqX09wcw?oc=5", "title": "Legrand, EssilorLuxottica et Michelin sur le podium gagnant du Cac 40 apr\u00e8s leurs r\u00e9sultats, le changement de direction chez Sanofi passe mal", "content_text": "Legrand, EssilorLuxottica et Michelin sur le podium gagnant du Cac 40 apr\u00e8s leurs r\u00e9sultats, le changement de direction chez Sanofi passe mal", "date_published": "2026-02-12T08:00:00+00:00", "authors": [{"name": "Les Echos"}], "tags": ["Market update", "SAN"], "_sharemaestro": {"country": "France", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "SAN", "name": "Sanofi", "sentiment_url": "https://sharemaestro.com/sentiment/43fce935-d89d-4a60-883a-3eedb25e8674/"}]}}, {"id": "source:fe0d5aa5c0aec43e1ba0bbeb1020c035dda4d6068ad2cce356e7783d02714c67", "url": "https://news.google.com/rss/articles/CBMi8AFBVV95cUxOSmxvRHIwU3ZSS2EyQnBrR0RzenVCdTA4R29vZjROV3k3bjVlOVVNY0pPWlo0a0hYaDdyS2FXRkVXeW9pekRTTnlDWVRSV3gxTGpGN1NEQnZWRUVub2NIdEFGR3gwdU5PTUxQaWlaUlFLcWJfRVYxamtzNHBnLVJxY0xySWxzZ2oxSHpUNG92UENQbGV5ZmtZeHlLV1k0amtpTUFRSEhRZzNPMS1rX2V6V3dLaGdzZUliZXg1aTlCZmpnZGh4eFJ0bWRDNWx1WEVGXzBEN29tZFoxMjd2Ry03THVKdmVIenNFSW9LamdDcHc?oc=5", "external_url": "https://news.google.com/rss/articles/CBMi8AFBVV95cUxOSmxvRHIwU3ZSS2EyQnBrR0RzenVCdTA4R29vZjROV3k3bjVlOVVNY0pPWlo0a0hYaDdyS2FXRkVXeW9pekRTTnlDWVRSV3gxTGpGN1NEQnZWRUVub2NIdEFGR3gwdU5PTUxQaWlaUlFLcWJfRVYxamtzNHBnLVJxY0xySWxzZ2oxSHpUNG92UENQbGV5ZmtZeHlLV1k0amtpTUFRSEhRZzNPMS1rX2V6V3dLaGdzZUliZXg1aTlCZmpnZGh4eFJ0bWRDNWx1WEVGXzBEN29tZFoxMjd2Ry03THVKdmVIenNFSW9LamdDcHc?oc=5", "title": "Sanofi affiche sa confiance pour 2026 apr\u00e8s des r\u00e9sultats 2025 sup\u00e9rieurs aux attentes", "content_text": "Sanofi affiche sa confiance pour 2026 apr\u00e8s des r\u00e9sultats 2025 sup\u00e9rieurs aux attentes", "date_published": "2026-01-29T08:00:00+00:00", "authors": [{"name": "Les Echos"}], "tags": ["Market update", "SAN"], "_sharemaestro": {"country": "France", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "SAN", "name": "Sanofi", "sentiment_url": "https://sharemaestro.com/sentiment/43fce935-d89d-4a60-883a-3eedb25e8674/"}]}}, {"id": "source:8a84e53a7caabefffc83ae5b162e8ab408094b7194434ce199ee75aa5cd5a699", "url": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxQRUVBZ24waTRQZ2gzTkNWbVdkbmNhWTRrNmxSSjFQcEFSTUd6TVYtZ1B3UGN2LXFTY0xFTjdJRDRZR1ZRRGlzVlZxR0xtb2RjZE1PdExYS0p1WVRfS3VwRHo4LVpteUpXaXViWkpfVGpqQ1dCVkNGY2o3bGdac1lmdEdqZ25VWEVBTjZlcklCaDhSZXZTbndoSThPa0ZidzlzZk5BNXBVZVpaYmhKejg5VEpXdmRQSG5TVWRZ?oc=5", "external_url": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxQRUVBZ24waTRQZ2gzTkNWbVdkbmNhWTRrNmxSSjFQcEFSTUd6TVYtZ1B3UGN2LXFTY0xFTjdJRDRZR1ZRRGlzVlZxR0xtb2RjZE1PdExYS0p1WVRfS3VwRHo4LVpteUpXaXViWkpfVGpqQ1dCVkNGY2o3bGdac1lmdEdqZ25VWEVBTjZlcklCaDhSZXZTbndoSThPa0ZidzlzZk5BNXBVZVpaYmhKejg5VEpXdmRQSG5TVWRZ?oc=5", "title": "Sanofi annonce un chiffre d\u2019affaires de plus de 43 milliards d\u2019euros en 2025", "content_text": "Sanofi annonce un chiffre d\u2019affaires de plus de 43 milliards d\u2019euros en 2025", "date_published": "2026-01-29T08:00:00+00:00", "authors": [{"name": "Sud Ouest"}], "tags": ["Market update", "SAN"], "_sharemaestro": {"country": "France", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "SAN", "name": "Sanofi", "sentiment_url": "https://sharemaestro.com/sentiment/43fce935-d89d-4a60-883a-3eedb25e8674/"}]}}, {"id": "source:815005ce4fbdcb3be9312a6826ac2ac041d87db2052f7f7612a4c3228a119c34", "url": "https://news.google.com/rss/articles/CBMi5AFBVV95cUxNZkY3bUZIUGdsLUM2RnVLanRzV3laQjJOS2kzdUhvUlFhbF8tbWlqTFREV1BmRms1SXBQMS1FaWFJNlNQYUU5Wnk5c2pJNGZSTlNBNEdfS3FRbmtZLUo0SWZmeW5SMUc0bDVKSDRCOXQycXBXMnRRSEVad1NnM2dGcGRfZlJ6UGEtSTg0Yk80dnFMNlJxa3p4QjZFRmFCUkFNWFNTYzdfYmV5UHIzYVJnRWxJVWdiQzVXa285ZGZFdW1GRkNwbVNRNDJ2dGxvZklqU3JoTGlSdThMNlB4UkFJb1VxaG8?oc=5", "external_url": "https://news.google.com/rss/articles/CBMi5AFBVV95cUxNZkY3bUZIUGdsLUM2RnVLanRzV3laQjJOS2kzdUhvUlFhbF8tbWlqTFREV1BmRms1SXBQMS1FaWFJNlNQYUU5Wnk5c2pJNGZSTlNBNEdfS3FRbmtZLUo0SWZmeW5SMUc0bDVKSDRCOXQycXBXMnRRSEVad1NnM2dGcGRfZlJ6UGEtSTg0Yk80dnFMNlJxa3p4QjZFRmFCUkFNWFNTYzdfYmV5UHIzYVJnRWxJVWdiQzVXa285ZGZFdW1GRkNwbVNRNDJ2dGxvZklqU3JoTGlSdThMNlB4UkFJb1VxaG8?oc=5", "title": "Sanofi pr\u00e9sente de bons r\u00e9sultats, mais d\u00e9\u00e7oit les investisseurs", "content_text": "Sanofi pr\u00e9sente de bons r\u00e9sultats, mais d\u00e9\u00e7oit les investisseurs", "date_published": "2026-01-29T08:00:00+00:00", "authors": [{"name": "La Tribune"}], "tags": ["Market update", "SAN"], "_sharemaestro": {"country": "France", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "SAN", "name": "Sanofi", "sentiment_url": "https://sharemaestro.com/sentiment/43fce935-d89d-4a60-883a-3eedb25e8674/"}]}}, {"id": "source:0e52984b7d7381ce16136f365cda5067e48975f8d173a16ba0ec70450ff09064", "url": "https://news.google.com/rss/articles/CBMiuAFBVV95cUxQanRBbDVyZVpOZVlWSmN1MndXbFpGYnRWUF9ybHVjNURNd05GZFBXX0NGS0NtOERFRkl5TzVmZTJ1UVlTVkowUE5PQUNHdU1zb180T3VTMUVwc1RWTVV3R3RDOXRuR3Rrdl9CLVMta0hyN0NNaV9ld2FnXzA2Q1hEangtTHBiV1lZcUt2bnlPNTZiR1VfRlZ0TWg5b2k4V2RlZWFCZVpRMy1DYWJTOUJZbFJXRVZDZDJk?oc=5", "external_url": "https://news.google.com/rss/articles/CBMiuAFBVV95cUxQanRBbDVyZVpOZVlWSmN1MndXbFpGYnRWUF9ybHVjNURNd05GZFBXX0NGS0NtOERFRkl5TzVmZTJ1UVlTVkowUE5PQUNHdU1zb180T3VTMUVwc1RWTVV3R3RDOXRuR3Rrdl9CLVMta0hyN0NNaV9ld2FnXzA2Q1hEangtTHBiV1lZcUt2bnlPNTZiR1VfRlZ0TWg5b2k4V2RlZWFCZVpRMy1DYWJTOUJZbFJXRVZDZDJk?oc=5", "title": "Sanofi va racheter pour un milliard d\u2019euros d\u2019actions apr\u00e8s des r\u00e9sultats solides", "content_text": "Sanofi va racheter pour un milliard d\u2019euros d\u2019actions apr\u00e8s des r\u00e9sultats solides", "date_published": "2026-01-29T08:00:00+00:00", "authors": [{"name": "L'Agefi"}], "tags": ["Market update", "SAN"], "_sharemaestro": {"country": "France", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "SAN", "name": "Sanofi", "sentiment_url": "https://sharemaestro.com/sentiment/43fce935-d89d-4a60-883a-3eedb25e8674/"}]}}, {"id": "source:312c754687e3e494df0a6786e02b415927795cdab1ce38da196133be6789fe95", "url": "https://news.google.com/rss/articles/CBMiowFBVV95cUxNb2tPLVd6UWlYMGxHQzc3Yl9qc1VkT0lwdGxPdzhoNHktZ1VTRG5KblNkNGhYbnZxd2Z2UnhGUHJhSzlnNTZibm5IbVljbkRtczhzMWZORnAxeGtMbnRfRVFDRTBIc1ZoLWJXZXc5enVfMHM0U3dQX1J3TUNFV3hwSUE0aWc3QzFfMGlOcHU4OUo1c2hOeXM5UlNkTWhyQmg1U1dn?oc=5", "external_url": "https://news.google.com/rss/articles/CBMiowFBVV95cUxNb2tPLVd6UWlYMGxHQzc3Yl9qc1VkT0lwdGxPdzhoNHktZ1VTRG5KblNkNGhYbnZxd2Z2UnhGUHJhSzlnNTZibm5IbVljbkRtczhzMWZORnAxeGtMbnRfRVFDRTBIc1ZoLWJXZXc5enVfMHM0U3dQX1J3TUNFV3hwSUE0aWc3QzFfMGlOcHU4OUo1c2hOeXM5UlNkTWhyQmg1U1dn?oc=5", "title": "Sanofi : l\u00e9g\u00e8re hausse apr\u00e8s les r\u00e9sultats", "content_text": "Sanofi : l\u00e9g\u00e8re hausse apr\u00e8s les r\u00e9sultats", "date_published": "2026-01-29T08:00:00+00:00", "authors": [{"name": "Boursier.com"}], "tags": ["Market update", "SAN"], "_sharemaestro": {"country": "France", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "SAN", "name": "Sanofi", "sentiment_url": "https://sharemaestro.com/sentiment/43fce935-d89d-4a60-883a-3eedb25e8674/"}]}}, {"id": "source:c8ade5c642db02b4aed361e06ff3897d5dca5182cc95735c9279c8dd40e31de7", "url": "https://news.google.com/rss/articles/CBMivAJBVV95cUxOVHdLN2k0OEk5bkxQY2llNjlxajVRQ3NsN21kN2x2VHZNcmlvY3ZBWVBJM3VGcVBYZTJoaTd2U25Hb1lMcjdwOXluMlJmOVZBcDY1SGJZT1A0TEVuUmhCdE54TGJZOGMyVTBZVktuVUFNazFRa3pFcnJXdTFPa29TTW84bHItNUkzUFQ0YnotZENKOGxFZFEwLTlySUhyTzNUSEpaRmZVbXhNOTc1TjM3cXhZMWJjVl9jOUhHNUVpSlZ6R1FDUnhfZHlCM1RBNkJ3X1prOVplWHZjNUlPNGN1QUdOenh1Ylozb3pMMGVOM0pwVEdxcENZUktJTW5RcXAzV2JONmhsVFh3Q3NXVDU2bjVBMWxkRHRDek1qQWtBeFUyUHNGQmJ0cFNabGFkek5aYXVpZ2xSRnQ5NmZm?oc=5", "external_url": "https://news.google.com/rss/articles/CBMivAJBVV95cUxOVHdLN2k0OEk5bkxQY2llNjlxajVRQ3NsN21kN2x2VHZNcmlvY3ZBWVBJM3VGcVBYZTJoaTd2U25Hb1lMcjdwOXluMlJmOVZBcDY1SGJZT1A0TEVuUmhCdE54TGJZOGMyVTBZVktuVUFNazFRa3pFcnJXdTFPa29TTW84bHItNUkzUFQ0YnotZENKOGxFZFEwLTlySUhyTzNUSEpaRmZVbXhNOTc1TjM3cXhZMWJjVl9jOUhHNUVpSlZ6R1FDUnhfZHlCM1RBNkJ3X1prOVplWHZjNUlPNGN1QUdOenh1Ylozb3pMMGVOM0pwVEdxcENZUktJTW5RcXAzV2JONmhsVFh3Q3NXVDU2bjVBMWxkRHRDek1qQWtBeFUyUHNGQmJ0cFNabGFkek5aYXVpZ2xSRnQ5NmZm?oc=5", "title": "De nouvelles statistiques am\u00e9ricaines au programme pour attendre les r\u00e9sultats d'Apple, Sanofi, Eurofins Scientific et STMicro sur le gril en France", "content_text": "De nouvelles statistiques am\u00e9ricaines au programme pour attendre les r\u00e9sultats d'Apple, Sanofi, Eurofins Scientific et STMicro sur le gril en France", "date_published": "2026-01-28T08:00:00+00:00", "authors": [{"name": "Les Echos"}], "tags": ["Market update", "SAN"], "_sharemaestro": {"country": "France", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "SAN", "name": "Sanofi", "sentiment_url": "https://sharemaestro.com/sentiment/43fce935-d89d-4a60-883a-3eedb25e8674/"}]}}, {"id": "source:f2d67650a1058ccd94ce623382930a11f80dbcf72194327941824cd4b8c40395", "url": "https://news.google.com/rss/articles/CBMiaEFVX3lxTE13VDZNWmNZVG12eXo1M254NWVacHN0dVJOeXJVbThVMnpGVlV0VjJ2NHA0MWp4VzE2TGhTR21lMll2bDU1Nm13Y0haLUlkclJKc0NkVTZhaUdNRDRmd1pDY3BYbDFyT090?oc=5", "external_url": "https://news.google.com/rss/articles/CBMiaEFVX3lxTE13VDZNWmNZVG12eXo1M254NWVacHN0dVJOeXJVbThVMnpGVlV0VjJ2NHA0MWp4VzE2TGhTR21lMll2bDU1Nm13Y0haLUlkclJKc0NkVTZhaUdNRDRmd1pDY3BYbDFyT090?oc=5", "title": "Pr\u00e9visions Action Sanofi 2026\u20132030 | Perspectives", "content_text": "Pr\u00e9visions Action Sanofi 2026\u20132030 | Perspectives", "date_published": "2026-01-14T08:00:00+00:00", "authors": [{"name": "Capital.com"}], "tags": ["Market update", "SAN"], "_sharemaestro": {"country": "France", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "SAN", "name": "Sanofi", "sentiment_url": "https://sharemaestro.com/sentiment/43fce935-d89d-4a60-883a-3eedb25e8674/"}]}}, {"id": "source:762469e8738ef6a4d268d6b59eaa6849ee5db2fe26b7d69a92670af6e5f4b04b", "url": "https://news.google.com/rss/articles/CBMiZ0FVX3lxTE1CVWRNaEY4cEZoR0FPVjh1VGxKQkFLamxBcllWRVhLeHJQMVVUZW5BUEI3YWpfN0IzalpOUUE0Vi1PN0xDYlRwakZQM3h3T0hmV29qOUkyNXBIdDJOSmc4Q0dqNHJCeVU?oc=5", "external_url": "https://news.google.com/rss/articles/CBMiZ0FVX3lxTE1CVWRNaEY4cEZoR0FPVjh1VGxKQkFLamxBcllWRVhLeHJQMVVUZW5BUEI3YWpfN0IzalpOUUE0Vi1PN0xDYlRwakZQM3h3T0hmV29qOUkyNXBIdDJOSmc4Q0dqNHJCeVU?oc=5", "title": "Pr\u00e9visions action Sanofi : objectifs de prix tiers", "content_text": "Pr\u00e9visions action Sanofi : objectifs de prix tiers", "date_published": "2026-01-14T08:00:00+00:00", "authors": [{"name": "Capital.com"}], "tags": ["Market update", "SAN"], "_sharemaestro": {"country": "France", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "SAN", "name": "Sanofi", "sentiment_url": "https://sharemaestro.com/sentiment/43fce935-d89d-4a60-883a-3eedb25e8674/"}]}}, {"id": "source:5c4ed7ebf3edd736e39ee72363d6b63f6ace63775de4d44d470c55720440493a", "url": "https://news.google.com/rss/articles/CBMilgJBVV95cUxNSE1jLURHbWFzT1RrRGMzYmZCZEdpa2s0OHh1SnJPY1JZYUxnQU5WMjFXaWJvLTctMm1tS25yellxU0JWS2JiVzdDRE1EYW9MVUlpNHVMMk1lem9vVWpkS01Pbk5wNTVhQ1RpWWVjLUZWeHRaa3AtblVjeTZyQkdNNTRkaUUzakc1WG4xTDBheGVYbzcwZ25zSE1wU3YxZERoUzRSRURyWjNhZ2dVVEI0WVNEdGkxemJ3TWpOaVlxb2pweXFtZnBwczMweEF0VnltUjhlSXR1clYwUEMwU2hwOU5vekpHY0tqa3Z1ZXpPbzZGek5YdWZpOEdDSVd3VVliWlRtWTZ2cFlJUDZLLTlFU0xpTHFjUQ?oc=5", "external_url": "https://news.google.com/rss/articles/CBMilgJBVV95cUxNSE1jLURHbWFzT1RrRGMzYmZCZEdpa2s0OHh1SnJPY1JZYUxnQU5WMjFXaWJvLTctMm1tS25yellxU0JWS2JiVzdDRE1EYW9MVUlpNHVMMk1lem9vVWpkS01Pbk5wNTVhQ1RpWWVjLUZWeHRaa3AtblVjeTZyQkdNNTRkaUUzakc1WG4xTDBheGVYbzcwZ25zSE1wU3YxZERoUzRSRURyWjNhZ2dVVEI0WVNEdGkxemJ3TWpOaVlxb2pweXFtZnBwczMweEF0VnltUjhlSXR1clYwUEMwU2hwOU5vekpHY0tqa3Z1ZXpPbzZGek5YdWZpOEdDSVd3VVliWlRtWTZ2cFlJUDZLLTlFU0xpTHFjUQ?oc=5", "title": "Valneva : De nouveaux r\u00e9sultats cliniques positifs sur son vaccin contre la maladie de Lyme portent Valneva en Bourse", "content_text": "Valneva : De nouveaux r\u00e9sultats cliniques positifs sur son vaccin contre la maladie de Lyme portent Valneva en Bourse", "date_published": "2025-11-26T08:00:00+00:00", "authors": [{"name": "BFM Bourse"}], "tags": ["Market update", "VLA"], "_sharemaestro": {"country": "France", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "VLA", "name": "Valneva SE", "sentiment_url": "https://sharemaestro.com/sentiment/29755642-e05f-4073-89cd-1a3af2a51d87/"}]}}, {"id": "source:126b3c97e72543641f1f1ac99be10c8f2377c6fb64b592ab7a02a56edf36f7c0", "url": "https://news.google.com/rss/articles/CBMi5gFBVV95cUxPYVVwMFB1NGdhTm1MdTROLUFHenNQaXYtX3dfMXl4NnZDLVNiSFdrYkZCYXRRX0g5Tm9pRVRpOWZmLXJ6NXUzbEkxbUhFUVg2N0hTbDN0ZXliV1pGT3ZKV0lIMnJpZGlCTXNZdXR2a0Fzc2hpNnp0cTF4QkRqcE9lbWpyU09aUDNFZFh0b055RDZYR0xmV0RRb3lTLTlReXdrb2dVNTdFZWFzU0hGRkdWOUV1dHRzWmEwNGNLZENkY2lJc05ld0Q2Y2VOY0VTS2VHdXNLVmNHdjhtNzVpaWlmUHJHSWluUQ?oc=5", "external_url": "https://news.google.com/rss/articles/CBMi5gFBVV95cUxPYVVwMFB1NGdhTm1MdTROLUFHenNQaXYtX3dfMXl4NnZDLVNiSFdrYkZCYXRRX0g5Tm9pRVRpOWZmLXJ6NXUzbEkxbUhFUVg2N0hTbDN0ZXliV1pGT3ZKV0lIMnJpZGlCTXNZdXR2a0Fzc2hpNnp0cTF4QkRqcE9lbWpyU09aUDNFZFh0b055RDZYR0xmV0RRb3lTLTlReXdrb2dVNTdFZWFzU0hGRkdWOUV1dHRzWmEwNGNLZENkY2lJc05ld0Q2Y2VOY0VTS2VHdXNLVmNHdjhtNzVpaWlmUHJHSWluUQ?oc=5", "title": "R\u00e9sultats de Sanofi : Une Forte Croissance des B\u00e9n\u00e9fices Soutient des Pr\u00e9visions Optimistes pour l\u2019Ensemble de l\u2019Ann\u00e9e", "content_text": "R\u00e9sultats de Sanofi : Une Forte Croissance des B\u00e9n\u00e9fices Soutient des Pr\u00e9visions Optimistes pour l\u2019Ensemble de l\u2019Ann\u00e9e", "date_published": "2025-10-27T07:00:00+00:00", "authors": [{"name": "Morningstar"}], "tags": ["Market update", "SAN"], "_sharemaestro": {"country": "France", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "SAN", "name": "Sanofi", "sentiment_url": "https://sharemaestro.com/sentiment/43fce935-d89d-4a60-883a-3eedb25e8674/"}]}}, {"id": "source:714fad8ce3f172d75c4a9183404546c7f7023ae44e863ecda2a5f9976f240874", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxOVkJZX3N0Y05NNHFGYm5idC1RR1dUWU1ROFpjZUVvUWEyX0JJZHJyX3NrREl3TC1leEpxYm5rQmpqT1hJdlZoTVZPeUlXUWRuLWxwR3hyZ0g1TVRFcU5ZOXNkT1pFdXh1aEVzWFN0Y2k0Vkt2ZDRnYkdKLTliTGNQSm16RmFDWUtsUTUySTJSNGFwYkVVSTVzZVdRd25BSkFqMmNKeDhvV2pJUHY1Vmc?oc=5", "external_url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxOVkJZX3N0Y05NNHFGYm5idC1RR1dUWU1ROFpjZUVvUWEyX0JJZHJyX3NrREl3TC1leEpxYm5rQmpqT1hJdlZoTVZPeUlXUWRuLWxwR3hyZ0g1TVRFcU5ZOXNkT1pFdXh1aEVzWFN0Y2k0Vkt2ZDRnYkdKLTliTGNQSm16RmFDWUtsUTUySTJSNGFwYkVVSTVzZVdRd25BSkFqMmNKeDhvV2pJUHY1Vmc?oc=5", "title": "Valneva reporte sa dette \u00e0 2030 et ajuste ses pr\u00e9visions \u00e0 la baisse", "content_text": "Valneva reporte sa dette \u00e0 2030 et ajuste ses pr\u00e9visions \u00e0 la baisse", "date_published": "2025-10-06T07:00:00+00:00", "authors": [{"name": "ABC Bourse"}], "tags": ["Market update", "VLA"], "_sharemaestro": {"country": "France", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "VLA", "name": "Valneva SE", "sentiment_url": "https://sharemaestro.com/sentiment/29755642-e05f-4073-89cd-1a3af2a51d87/"}]}}]}